Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD
暂无分享,去创建一个
L. Barbeito | P. Crouch | Nathan I. Lopez | M. Franco | J. Beckman | B. Roberts | C. Pereira | Emiliano Trias | Edwin M. Labut | E. McAllum | A. Estevez | J. Elliott | C. Bradford | T. Rhoads | Jared R. Williams | Pamela R. Beilby | M. Son | C. Samuel Bradford | Blaine R. Roberts | Peter J. Crouch | Jeffrey L. Elliott | Maria Clara Franco | Alvaro G. Estévez | Joseph S. Beckman | P. Crouch
[1] J. Gitlin,et al. X‐linked spinal muscular atrophy in mice caused by autonomous loss of ATP7A in the motor neuron , 2015, The Journal of pathology.
[2] Blaine R. Roberts,et al. Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2014, The Journal of Neuroscience.
[3] J. Prohaska. Impact of copper deficiency in humans , 2014, Annals of the New York Academy of Sciences.
[4] J. Elliott,et al. Mitochondrial defects in transgenic mice expressing Cu,Zn Superoxide Dismutase mutations, the role of Copper Chaperone for SOD1 , 2014, Journal of the Neurological Sciences.
[5] James L. Hickey,et al. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[6] Victoria Del Gaizo Moore,et al. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part I, background and methods , 2013, Brain and behavior.
[7] Victoria Del Gaizo Moore,et al. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part II, results and discussion , 2013, Brain and behavior.
[8] S. Marklund,et al. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities , 2013, Neurobiology of Disease.
[9] M. Beal,et al. Nitration of Hsp90 induces cell death , 2013, Proceedings of the National Academy of Sciences.
[10] P. Crouch,et al. Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes , 2012, PloS one.
[11] Blaine R. Roberts,et al. The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease , 2012, The Journal of experimental medicine.
[12] D. A. Bosco,et al. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1 , 2012, Proceedings of the National Academy of Sciences.
[13] Nathan I. Lopez,et al. Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice , 2012, Neurobiology of Disease.
[14] P. Crouch,et al. An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII , 2011, Proceedings of the National Academy of Sciences.
[15] J. Glass,et al. In Vivo Pathogenic Role of Mutant SOD1 Localized in the Mitochondrial Intermembrane Space , 2011, The Journal of Neuroscience.
[16] James L. Hickey,et al. Diacetylbis(N(4)-methylthiosemicarbazonato) Copper(II) (CuII(atsm)) Protects against Peroxynitrite-induced Nitrosative Damage and Prolongs Survival in Amyotrophic Lateral Sclerosis Mouse Model* , 2011, The Journal of Biological Chemistry.
[17] Nathan I. Lopez,et al. Measuring copper and zinc superoxide dismutase from spinal cord tissue using electrospray mass spectrometry. , 2011, Analytical biochemistry.
[18] D. Borchelt,et al. Copper and Zinc Metallation Status of Copper-Zinc Superoxide Dismutase from Amyotrophic Lateral Sclerosis Transgenic Mice* , 2010, The Journal of Biological Chemistry.
[19] Jeffery N Agar,et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS , 2010, Nature Neuroscience.
[20] I. Bertini,et al. Affinity gradients drive copper to cellular destinations , 2010, Nature.
[21] A. Packard,et al. Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM. , 2010, Nuclear medicine and biology.
[22] T. Ferguson,et al. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. , 2010, American journal of human genetics.
[23] J. Beckman,et al. A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis. , 2009, Antioxidants & redox signaling.
[24] P. Caroni,et al. A role for motoneuron subtype–selective ER stress in disease manifestations of FALS mice , 2009, Nature Neuroscience.
[25] Can Kayatekin,et al. Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase. , 2008, Journal of molecular biology.
[26] D. Winge,et al. Isolated Cytochrome c Oxidase Deficiency in G93A SOD1 Mice Overexpressing CCS Protein* , 2008, Journal of Biological Chemistry.
[27] K. Talbot,et al. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS , 2008, Progress in Neurobiology.
[28] J. E. Kranz,et al. Design, power, and interpretation of studies in the standard murine model of ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[29] P. Boyer,et al. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology , 2007, Proceedings of the National Academy of Sciences.
[30] A. Naganuma,et al. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis. , 2007, Toxicology.
[31] E. Bigio,et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] P. Andersen,et al. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. , 2006, Brain : a journal of neurology.
[33] Zuoshang Xu,et al. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. , 2005, Mitochondrion.
[34] J. G. Penland,et al. Abnormal motor function persists following recovery from perinatal copper deficiency in rats. , 2004, The Journal of nutrition.
[35] T. O’Halloran,et al. Oxygen and the copper chaperone CCS regulate posttranslational activation of Cu,Zn superoxide dismutase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] Robert H. Brown,et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[37] A. Chakrabartty,et al. Oxidation-induced Misfolding and Aggregation of Superoxide Dismutase and Its Implications for Amyotrophic Lateral Sclerosis* , 2002, The Journal of Biological Chemistry.
[38] J. Prohaska,et al. The timing of perinatal copper deficiency in mice influences offspring survival. , 2002, The Journal of nutrition.
[39] M. Beal,et al. Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice* , 2002, The Journal of Biological Chemistry.
[40] Jason S. Lewis,et al. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships , 2002, JBIC Journal of Biological Inorganic Chemistry.
[41] J. Holstege,et al. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations , 2001, Acta Neuropathologica.
[42] A. Lamb,et al. Heterodimer formation between superoxide dismutase and its copper chaperone. , 2000, Biochemistry.
[43] Steven D. P. Moore,et al. Cloning and mapping of murine superoxide dismutase copper chaperone (Ccsd) and mapping of the human ortholog , 2000, Cytogenetic and Genome Research.
[44] J S Beckman,et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. , 1999, Science.
[45] D. Price,et al. The Copper Chaperone CCS Is Abundant in Neurons and Astrocytes in Human and Rodent Brain , 1999, Journal of neurochemistry.
[46] J. Kong,et al. Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1 , 1998, The Journal of Neuroscience.
[47] C. Levenson,et al. Long-term measurement of organ copper turnover in rats by continuous feeding of a stable isotope. , 1994, Analytical biochemistry.
[48] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[49] J. Prohaska. Changes in Cu,Zn-superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-deficient mice and rats. , 1991, The Journal of nutrition.
[50] Nathan I. Lopez,et al. Using Theoretical Protein Isotopic Distributions to Parse Small-Mass-Difference Post-Translational Modifications via Mass Spectrometry , 2012, Journal of The American Society for Mass Spectrometry.
[51] L. Barbeito,et al. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis , 2002, Journal of neuroscience research.